Literature DB >> 9850605

Nitric oxide: from discovery to the clinic.

S Lamas1, D Pérez-Sala, S Moncada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9850605     DOI: 10.1016/s0165-6147(98)01265-6

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  11 in total

Review 1.  Nitric oxide: an emerging role in cardioprotection?

Authors:  R D Rakhit; M S Marber
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

Review 2.  Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies.

Authors:  Michael A Collins; Edward J Neafsey; Kenneth J Mukamal; Mary O Gray; Dale A Parks; Dipak K Das; Ronald J Korthuis
Journal:  Alcohol Clin Exp Res       Date:  2008-11-19       Impact factor: 3.455

3.  Biomimetic modification of metallic cardiovascular biomaterials: from function mimicking to endothelialization in vivo.

Authors:  Yajun Weng; Junying Chen; Qiufen Tu; Quanli Li; Manfred F Maitz; Nan Huang
Journal:  Interface Focus       Date:  2012-03-28       Impact factor: 3.906

Review 4.  Nitric oxide signaling in hypoxia.

Authors:  J J David Ho; H S Jeffrey Man; Philip A Marsden
Journal:  J Mol Med (Berl)       Date:  2012-02-18       Impact factor: 4.599

5.  Increased mitochondrial prooxidant activity mediates up-regulation of Complex I S-glutathionylation via protein thiyl radical in the murine heart of eNOS(-/-).

Authors:  Patrick T Kang; Chwen-Lih Chen; Yeong-Renn Chen
Journal:  Free Radic Biol Med       Date:  2014-11-28       Impact factor: 7.376

6.  Excess no predisposes mitochondrial succinate-cytochrome c reductase to produce hydroxyl radical.

Authors:  Jingfeng Chen; Chwen-Lih Chen; B Rita Alevriadou; Jay L Zweier; Yeong-Renn Chen
Journal:  Biochim Biophys Acta       Date:  2011-03-22

7.  Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Prodrugs as Drug Candidates for the Treatment of Ischemic Disorders: Insights into NO-Releasing Prodrug Biotransformation and Hemoglobin-NO Biochemistry.

Authors:  Guoyan G Xu; Tanvi M Deshpande; Mohini S Ghatge; Akul Y Mehta; Abdel Sattar M Omar; Mostafa H Ahmed; Jurgen Venitz; Osheiza Abdulmalik; Yan Zhang; Martin K Safo
Journal:  Biochemistry       Date:  2015-12-03       Impact factor: 3.162

8.  Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.

Authors:  Emmanuel Eroume A Egom; Tamer M A Mohamed; Mamas A Mamas; Ying Shi; Wei Liu; Debora Chirico; Sally E Stringer; Yunbo Ke; Mohamed Shaheen; Tao Wang; Sanoj Chacko; Xin Wang; R John Solaro; Farzin Fath-Ordoubadi; Elizabeth J Cartwright; Ming Lei
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-24       Impact factor: 4.733

9.  JS-K, a nitric oxide prodrug, has enhanced cytotoxicity in colon cancer cells with knockdown of thioredoxin reductase 1.

Authors:  Kornelia Edes; Pamela Cassidy; Paul J Shami; Philip J Moos
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

10.  Suppression of nitric oxide production in mouse macrophages by soybean flavonoids accumulated in response to nitroprusside and fungal elicitation.

Authors:  Loren S Scuro; P U Simioni; D L Grabriel; Elzira E Saviani; Luzia V Modolo; Wirla M S C Tamashiro; Ione Salgado
Journal:  BMC Biochem       Date:  2004-04-21       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.